Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00129285 · ClinicalTrials.gov registry record · Phase 2

Modafinil Treatment for Cocaine-Dependent Individuals

A Phase 2 study, sponsored by University of Pennsylvania.

Completed
Registry status
Phase 2
Development phase
210
Enrollment target

NCT00129285: Completed Phase 2 study, sponsored by University of Pennsylvania.

NCT00129285 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 210 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (58% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00129285, a Phase 2 study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
Phase 2
Development phase
210 participants
Enrollment target

Study Summary

Despite years of active research, there are still no approved medications for the treatment of cocaine dependence. The purpose of this study is to determine the effectiveness of modafinil in treating cocaine-dependent individuals.

Primary Outcome

Abstinent in the final 3 weeks of treatment

Interventions

  • DRUG Placebo
  • DRUG Low Dose Modafinil
  • DRUG High Dose Modafinil

Trial Details

FieldValue
Enrollment Target 210 participants
Start Date 2004-07
Est. Completion 2008-04
Phase Phase 2
University of Pennsylvania

1,423 total trials

What the finished NCT00129285 record still lists

NCT00129285 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (58% higher).

The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.

NCT00129285 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00129285 about?

NCT00129285 is a clinical study titled "Modafinil Treatment for Cocaine-Dependent Individuals". Despite years of active research, there are still no approved medications for the treatment of cocaine dependence. The purpose of this study is to determine the effectiveness of modafinil in treating cocaine-dependent individuals.

What is the current status of trial NCT00129285?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 210 participants. The study started on 2004-07. Estimated completion is 2008-04.

What interventions are being tested in trial NCT00129285?

The interventions under investigation include: Placebo (DRUG), Low Dose Modafinil (DRUG), High Dose Modafinil (DRUG).

Who is sponsoring clinical trial NCT00129285?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00129285's enrollment target sits among peer trials

210 290th of 2000 higher than 1,707 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02665923 · 210 participants

    Gastric Emptying in Neonates and Infants After Formula Feeding

  • NCT03322891 · 210 participants · NA

    Improving Health Literacy in African-American Prostate Cancer Patients

  • NCT03544489 · 210 participants · Phase 2

    Effectiveness of Exercise After an ICD

  • NCT04408430 · 210 participants · NA

    The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00129285, the US trial registry maintained by the National Library of Medicine. NCT00129285 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.